Safety, tolerability, and efficacy of high versus low-dose, short versus long-course daily primaquine for the radical cure of uncomplicated Plasmodium vivax malaria in children under 15 years of age: an open-label, non-inferiority, randomized controlled trial (CHILDPRIM)
一项开放标签、非劣效性、随机对照试验（CHILDPRIM），比较高剂量与低剂量、短期与长期每日服用伯氨喹治疗 15 岁以下儿童单纯性间日疟的安全性、耐受性和疗效。
期刊:Malaria Journal
影响因子:3
doi:10.1186/s12936-025-05686-y
Pacheco, Ana Luisa O; Omena, Aretha G; Baía-da-Silva, Djane C; Jardim, Tyane A P; Silva, Debora C B; Lopes, Adriana P B; Barbosa, Laila R A; Souza, Ingrid G; Araujo, Renata F; Nogueira, Luis O S; Vale, Suianne C N; Melo, Gisely C; Cordeiro, Jady S M; Bassat, Quique; Sampaio, Vanderson S; Lima, Valéria D S; Martinez-Espinosa, Flor E; Mourão, Maria Paula G; Monteiro, Wuelton M; Alecrim, Maria Graças C; Brito-Sousa, Jose Diego; Lacerda, Marcus V G
